Cadila seeks regulatory approval for COVID-19 drug

Indian drugmaker Cadila Healthcare Ltd said on Monday it would seek local regulatory approval to treat COVID-19 patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2QXS6eC
via IFTTT